Biotech · Private company
Biosplice Therapeutics, Inc.
Track this companyFree. Adds Biosplice Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials191 recruiting or active
Pipeline programs24From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline24
- LorecivivintPhase 3 · Knee OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- LorecivivintPhase 3 · Osteoarthritis of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- LorecivivintPhase 3 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
- ShamPhase 2 · Knee OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- SM04690Phase 2 · OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- SM04690Phase 2 · Knee OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- Topical SM04554 solutionPhase 2 · Androgenetic AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- Topical vehicle solutionPhase 2 · Androgenetic AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- AbirateronePhase 1 · Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 1 · Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- FOLFIRI ProtocolPhase 1 · Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Lorecivivint (LOR)Phase 1 · Drug-Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- PanitumumabPhase 1 · Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- PrednisonePhase 1 · Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- SM04690Phase 1 · Degenerative Disc DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SM04755Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- SM04755Phase 1 · TendinopathyClinicalTrials.gov · fetched Nov 12, 2026
- SM08502Phase 1 · Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- SM08502Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Sodium lauryl sulfatePhase 1 · TendinopathyClinicalTrials.gov · fetched Nov 12, 2026
- Triamcinolone acetonide (TA)Phase 1 · Drug-Drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 1 · TendinopathyClinicalTrials.gov · fetched Nov 12, 2026
- White PetrolatumPhase 1 · TendinopathyClinicalTrials.gov · fetched Nov 12, 2026
- Not applicable (no therapy is administered as part of this study)OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials19
- Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)PHASE1_PHASE2 · RECRUITING · started Dec 18, 2025ClinicalTrials.gov NCT07155200 · fetched Nov 12, 2026
- Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (STRIDES)PHASE3 · COMPLETED · started Nov 18, 2022ClinicalTrials.gov NCT05603754 · fetched Nov 12, 2026
- A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid TumorsPHASE1 · TERMINATED · started Nov 3, 2021ClinicalTrials.gov NCT05084859 · fetched Nov 12, 2026
- 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee OsteoarthritisPHASE3 · TERMINATED · started Jul 15, 2021ClinicalTrials.gov NCT04931667 · fetched Nov 12, 2026
- Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy VolunteersPHASE1 · COMPLETED · started Oct 13, 2020ClinicalTrials.gov NCT04598542 · fetched Nov 12, 2026
- A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the KneePHASE3 · TERMINATED · started Aug 25, 2020ClinicalTrials.gov NCT04520607 · fetched Nov 12, 2026
- Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)PHASE3 · COMPLETED · started May 26, 2020ClinicalTrials.gov NCT04385303 · fetched Nov 12, 2026
- Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee OsteoarthritisPHASE3 · COMPLETED · started May 17, 2019ClinicalTrials.gov NCT03928184 · fetched Nov 12, 2026
- MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee OsteoarthritisPHASE2 · TERMINATED · started Mar 11, 2019ClinicalTrials.gov NCT03706521 · fetched Nov 12, 2026
- Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee OsteoarthritisPHASE2 · COMPLETED · started Nov 28, 2018ClinicalTrials.gov NCT03727022 · fetched Nov 12, 2026
- A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid TumorsPHASE1 · TERMINATED · started Nov 6, 2017ClinicalTrials.gov NCT03355066 · fetched Nov 12, 2026
- A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy VolunteersPHASE1 · COMPLETED · started Sep 11, 2017ClinicalTrials.gov NCT03502434 · fetched Nov 12, 2026
- A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc DiseasePHASE1 · TERMINATED · started Jul 26, 2017ClinicalTrials.gov NCT03246399 · fetched Nov 12, 2026
- A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee OsteoarthritisPHASE2 · COMPLETED · started Apr 24, 2017ClinicalTrials.gov NCT03122860 · fetched Nov 12, 2026
- An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic OsteoarthritisCOMPLETED · started Sep 19, 2016ClinicalTrials.gov NCT02951026 · fetched Nov 12, 2026
- A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis SubjectsPHASE2 · COMPLETED · started Sep 9, 2015ClinicalTrials.gov NCT02536833 · fetched Nov 12, 2026
- A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post DosingPHASE2 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02503137 · fetched Nov 12, 2026
- A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)PHASE2 · COMPLETED · started Nov 1, 2014ClinicalTrials.gov NCT02275351 · fetched Nov 12, 2026
- Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic CancerPHASE1 · COMPLETED · started Jun 19, 2014ClinicalTrials.gov NCT02191761 · fetched Nov 12, 2026